welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
active, not recruiting

Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)

key information

study id #: NCT02606136

condition: Duchenne Muscular Dystrophy

status: active, not recruiting


This is a Phase 2, open-label, single arm trial of pamrevlumab (FG-3019) to estimate pamrevlumab’s safety and efficacy in non-ambulatory subjects with DMD.

intervention: pamrevlumab (FG-3019)

mechanism of action: Fibrosis preventor to support muscle

results: https://clinicaltrials.gov/ct2/show/results/NCT02606136

last updated: July 19, 2020